Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Rapid Infusion Rituximab in a Pilot Group of Adolescents With Hematologic, Oncologic, and Rheumatologic Disorders

NCT02484053 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02484053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02484053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Rapid Infusion Rituximab in a Pilot Group of Adolescents With Hematologic, Oncologic, and Rheumatologic Disorders
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2015
Completion date
January 31, 2017
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic disorders, oncologic disorders, rheumatologic disorders